This is where we should have some introductory text to flesh the page out a little bit and explain to the user what they can expect to find on this page.This is where we should have some introductory text to flesh the page out a little bit and explain to the user what they can expect to find on this page.This is where we should have some introductory text to flesh the page out a little bit and explain to the user what they can expect to find on this page.

This is where we should have some introductory text to flesh the page out a little bit and explain to the user what they can expect to find on this page.This is where we should have some introductory text to flesh the page out a little bit and explain to the user what they can expect to find on this page.This is where we should have some introductory text to flesh the page out a little bit and explain to the user what they can expect to find on this page.

Atrial Fibrillation Anticoagulation Resources

(Beds & Luton)

The following documents have been retired – please contact the Team for further information.

Common Drug Interactions with NOACs

NOACs – Patient information sheet

NOACs – table of comparison

PAC Atrial Fibrillation Anticoagulant clinical decision aid

UKCPA Guidance of Safe Switching of Warfarin to NOACs

Atrial Fibrillation Patient Information and Decision Aid

Bulletin 224 – Choice of NOAC for Anticoagulation in Atrial Fibrillation

Calculating Renal Function when Prescribing NOACs for non-valvular Atrial Fibrillation


To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net